Metformin Stada (Metformin Hydrochloride)

Metformin Hydrochloride lowers blood glucose primarily by inhibiting hepatic gluconeogenesis and reducing intestinal glucose absorption. It also enhances peripheral insulin sensitivity through activation of AMP‑activated protein kinase (AMPK), which together help to decrease circulating glucose levels without increasing insulin secretion.

The appropriate dose of Metformin Stada is individualized by the prescribing healthcare professional based on the patient’s renal function, glycaemic targets, tolerability, and overall clinical condition. Dosage adjustments are made during treatment to achieve optimal blood‑glucose control while minimizing adverse effects.

Metformin Stada is classified as a pregnancy‑category drug only when the potential benefit outweighs the risk. It may be used during pregnancy for gestational diabetes if deemed necessary, but routine use is not universally recommended. Limited data are available for breastfeeding; clinicians should assess the risk‑benefit ratio before prescribing.

To order Metformin Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Metformin Stada belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, or SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and has a favourable impact on weight. It is often first‑line therapy because of its efficacy, low cost, and cardiovascular safety profile compared with many newer agents.

Metformin Stada should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Metformin Stada is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water. The exact dosing schedule and timing are determined by the prescribing clinician based on individual therapeutic goals.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, hypoxia, or acute illness. Other serious risks include severe skin reactions such as Stevens‑Johnson syndrome and significant vitamin B12 deficiency with long‑term use.

Metformin Stada is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and in those with conditions predisposing to lactic acidosis such as severe heart failure or uncontrolled sepsis. Caution is also advised in pregnant or lactating women and in patients with hepatic disease.